Salute e Benessere
Astraveus Enters Strategic Partnership with NecstGen to evaluate Lakhesys Benchtop Cell Factory™ for CAR-T therapy manufacturing
Astraveus recently demonstrated the potential of its revolutionary Lakhesys Benchtop Cell Factory™ with the first ever, end-to-end production of CAR-T cells within a microfluidic benchtop system and is now starting external testing of its new manufacturing platform. Astraveus' technology, and its unique microfluidic approach, possesses the ability to simultaneously decrease manufacturing costs as well as increase process efficiency and throughput many times over.
"
Located at the Leiden Bio Science Park, one of Europe's largest life science clusters, NecstGen supports academic, small, and large industrial therapy developers to translate research and early-stage clinical programs into patient treatments.
Astraveus is a Paris -based life science company dedicated to making cell therapies with maximized quality at order-of-magnitude lower cost. With the unique Lakhesys Benchtop Cell Factory™, Astraveus provides bioprocessing innovation at the cellular level, utilizing cutting-edge microfluidic technology to enhance process optimization and scalability from pre-clinical to commercial manufacturing.
Founded in 2016 by Jérémie Laurent at the Saint-Louis Hospital in
Paris , a prestigious hub for leading cell therapy research, Astraveus is committed to revolutionizing the development and manufacturing of cell therapies and aspires to make these innovative treatments accessible to everyone in need, thereby enabling a healthier tomorrow.
www.astraveus.com
NecstGen is a non-profit CDMO and centre of excellence for Cell and Gene Therapy, located in a purpose-built GMP facility at the Leiden Bio Science Park, the largest bio-cluster in the Netherlands . NecstGen provides critical contract development, manufacturing and rental services to academic and industrial therapy developers to deliver next-generation therapeutics to patients.
View original content:https://www.prnewswire.co.uk/news-releases/astraveus-enters-strategic-partnership-with-necstgen-to-evaluate-lakhesys-benchtop-cell-factory-for-car-t-therapy-manufacturing-302445183.html